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Maine AIDS Care
Maine Medical Center's

AIDS Consultation Service

Nutrition & HIV
From the earliest descriptions of
AIDS in the United States, weight loss
has been an initial complaint of a
significant number of HIV-infected
persons. In 1987, the CDC included
HIV wasting syndrome as an indicator
disease of AIDS in the revised
surveillance case definition. Prospective
and retrospective investigations have
shown that 91 % to 100% of people with
AIDS lose weight. In a report published
in 1990, the Federation of American
Societies for Experimental Biology
(F ASEB) concluded that wasting and
malnutrition were common occurrences
in HIV disease; however, the extent of
specific nutrient deficiencies was unclear
and continues to be researched 1 •
Decrease in body weight, percent body
fat, and body mass index have been
observed in patients in the early stages
of infection 2 •
The development of malnutrition
in patients with HIV infection is
multifactorial and is thought to be an
interplay between a decrease or
alteration of food intake, malabsorption
of ingested nutrients, and altered body
metabolism characteristic of the disease
process 1 •
Factors contributing to reduced
food intake include anorexia, oral or
esophageal lesions, nausea and vomiting,
diarrhea, and neurologic or psychologic
complications 3 •
Additional factors
related to reduced food intake may also
include the presence and severity of
fatigue and it's impact on the patient's
ability to obtain and prepare food; lack
of money to buy food; lack of
knowledge or interest in nutrition and
HIV disease; and side effects of
medications 1 •
Nutritional

malabsorption

is

related to small intestine injury, but
disease of other digestive organs (ie.
stomach, liver, pancreas) contribute as
well. Researchers have identified three
categories of intestinal disease: primary
HIV infection of the enterocytes,
secondary involvement from systemic or
otherwise disseminated disorders (ie.
MAI, etc.), and a syndrome of
inflammatory bowel disease that may be
related to an identifiable pathogen or
cancer. Patients with malabsorption do
not increase intake sufficiently to
compensate for lost calories. Systemic
infections can also contribute to anorexia
due to cytokine-mediated inhibition of
appetite 1 •
Persons with clinically stable
HIV disease conserve lean body mass
even with losses of body weight caused
by decreased intake or malabsorption.
However, patients with AIDS who have
active disease, such as an opportunistic
infection with fever, commonly are
hypermetabolic and burn excessive

calories, resulting in wasting. One
research study reported metabolic
rates 20-60 % above predicted levels
in HIV infected persons with acute
systemic illness or with chronic
infection. Another study reported
that even in the absence of acute
illness, persons infected with HIV
had high rates of resting energy
expenditure (REE) resulting in
weight loss 1•
Kotler and colleagues studied
the impact of malnutrition on
survival of persons with AIDS and
found that death from wasting in
AIDS is related to the magnitude of
tissue depletion and is independent of
the underlying cause of wasting.
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Stavudine (D4T)
Approved by FDA
Stavudine (Zerit), a new
reverse transcriptase inhibitor, has
been approved by the FDA for
treatment of HIV+ patients who can
not tolerate or are not benefiting
from other approved therapies (ie.
AZT, DDI, DDC).
It is not
approved for use in combination
antiretroviral therapy. The efficacy
of Stavudine relative to other
available antiretrovirals is still not
clearly established. It is generally
well tolerated, although 15-20% of
patients may develop peripheral
neuropathy which is usually
reversible with discontinuation of the
drug. The approved dose is 40 mg
bid at a cost of approximately
$186.00 for 60 capsules. Bristol
Meyers Squibb Co. the
manufacturer, will provide the drug
to patients who can not afford it
through an assistance program. For
more information call Bristol-Meyers
Squibb at 1-800-788-0213.

AIDS Consultation Service
Treatment lnfonnation
Hotline
1-800-871-2701
Monday - Friday 9:00 - 4:30

Entera/, vs. Parenteral,
Nutrition in HIV
For patients with severe
malnutrition, recent research has shown
that enteral nutrition is preferable to
parenteral nutrition in that enteral
nutrition appears to preserve the gut
function and maintain gut integrity.
However, studies addressing the efficacy
of enteral support in HIV+ patients
remain scant.
Lowfat, elemental
formulas seem to work better with
diarrhea and malabsorption syndromes.
Parenteral nutrition may be
indicated for patients who demonstrate
intolerance to enteral feedings, have
bowel obstruction, sever pancreatitis,
copious/high volume diarrhea,
intractable vomiting, or in malnourished
patients who require prolonged bowel
rest. It should not be used in HIV+
patients who have functional GI tracts.
Total parenteral nutrition (TPN) should
not be used unless the prognosis
warrants aggressive nutritional
intervention. Some patients with end
stage AIDS might be better supported
with IV dextrose and vitamins and
minerals to meet hydration and basic
physiological needs without aggressive
nutritional support 1 • A key issue in the
provision of TPN to patients with AIDS
is the concern about infection. TPN can
lead to systemic infections, and there
may be a heightened risk in the AIDS
patient.
The efficacy of TPN in the
restoration of lean body mass HIV+
patients is under investigation. Studies
show variable results on body
composition, with increased fat stores
seen in the majority of patients, but
increased protein mass in only a few.
I

Flaslcerud, J .H. and Ungvarslci , P.J ., HIV/AIDS : A
Guide to Nursing Care, W.B. Saunders Co,
Philadelphia, 1992.
1
McCorlcindale, C ., Dybevilc, K., Coulsten AM , et al.
Journal American Dietetic Association, 1990; 90 .
• Kotler, D.P. (1991) Biological and Clinical Features
of HIV Infection In Gastrointestinal and Nutritional
Manifestation of the Acquired Immunodeficiency
Syndrome (ed . Kotler, D .P.) New York: Raven Press.
• Malnutrition in Acquired Immunodeficiency
Syndrome : Causes and Treatment, Mead-Johnson,
1994.
' Watson, Ronald R. (ed .) Nutrition and AIDS, Ann
Arbor; CRC Press 1994.
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They concluded that attempts to
maintain body mass could prolong
survival in persons with AIDS 1•
In AIDS patients, the disease
related abnormalities in immune function
make it difficult to interpret the effects
of malnutrition on immune function in
isolation from disease-related effects.
However, deficiencies in essential
nutrients may indeed compound the
immunodeficiency characteristic of
AIDS,
rendering patients more
susceptible to infections or exacerbating
the severity of existing infections. Since
not all patients with AIDS suffer from
repeated infections, it is thought that the
impaired immune system in AIDS
patients may be better equipped to
withstand certain environmental
pathogens in the absence of malnutrition.
Numerous micronutrient
deficiencies have been observed in HIVinfected patients. In one study of the
prevalence of abnormalities of plasma
vitamin and trace element concentrations
in 30 HIV infected patients, one or more
abnormalities were found in the majority
of patients. There have been reports of
low serum zinc, selenium, and vitamin
812 levels. The prevalence of folate
deficiency is variable and depends on the
dietary habits of individual patients.
Deficiencies of vitamins A, E, 8 6 , C,
choline, and carotenes have also been
noted4 •
These numerous micronutrient
deficiencies may have detrimental effects
on various organ systems, including the
immune system, even in otherwise
healthy individuals . It can thus be
speculated that the deleterious effects of
the immune system may be even greater
in HIV infected persons, who already
have a defective immune system from
viral activity alone.
Some effects of malnutrition on
immune functions are direct, while
others are secondary, resulting from
effects on other organ systems having
immune regulatory functions or from the
negative effects on all cellular
metabolism, including cells of the
immune system.
Virtually all
components of the immune system may
be affected by malnutrition, including
cell-mediated and humoral immunity, the
complement system, the production of
cytokines, and phagocytosis 1 •

Because of the multifactorial
nature of malnutrition in HIV disease,
and because of the wide-ranging effects
of malnutrition on the immune system,
early monitoring, detection, and
intervention regarding the nutritional
management of HIV infected persons is
essential. Each nutritional care plan
should be individualized to meet the
specific needs of the patient. It is
imperative that the patient have an active
role in the plan in an effort to optimize
commitment and compliance.
Efforts to improve oral food
intake are an important first step . These
include providing nutritional counseling
and education as soon as HIV disease is
diagnosed, emphasizing adequate protein
and calorie intake (high protein I high
carbohydrate) and encouraging the
appropriate servings of the four food
groups . Supplementing the diet with
multivitamin and mineral preparations
containing 100 % of the recommended
daily allowance for all micronutrients is
also appropriate. Although there is no
scientific evidence that megadoses of any
vitamin or mineral will alter the course
of AIDS, much attention is being paid
currently to so-called anti-oxidant
therapies .
We encourage careful
scrutiny of these therapies , as further
clinical trials are needed to confirm their
efficacy and identify adverse side
effects.
In addition to assuring adequate
food intake of HIV-positive patients,
development of rational strategies should
be a high priority in their over-all care.
It is imperative to rule out any and all
causes of wasting, and to treat those
underlying causes with drug or other
appropriate therapy, while at the same
time giving consideration to the best and
most important nutritional strategies for
that individual patient at that point in
time.

If you have questions or concerns
regarding HIV and NutriJion, the
AIDS Consultation Service's
Nutritional. Constdtant, Pamela
Perkins is available for questions by
calling the AIDS lnfonnation Hotline
at 1-800-871-2701.

Clinical Strategies in Provision of Nutritional
Support for Persons with HIV
I.

II.

m.

Assessment of Nutritional Status
A.

Regular chart of weight.

B.

Consider referral to registered dietitian for complete assessment.

C.

Key lab values to follow: albumin, cholesterol, triglycerides, H&H

General Principles of Nutrition for HIV
A.

Encourage high calorie, nutrient dense foods.

B.

Increase number and size of meals.

C.

Use calorie containing condiments and add calorie containing supplements
as needed.

D.

Encourage daily multivitamin with 100% daily recommended allowances.

Other Strategies to Increase Calorie Intake in Patients with Weight Loss
A.

Rule out opportunistic infection if low CD4 count (MAI, enteric parasites/bacteria)

B.

Rule out depression if low calorie intake. (Refer to arlicle on Depression & HIV)

C.

Consider enteral supplementation
1.
2.

D.

Intact formulas (Protein derived from sodium & calcium caseinate, soy protein
isolate, such as Ensure, Jevity, or Osmolite HN)
Specific formulas
Fat malabsorption : (Modified fat such as Lipisorb)
Elemental: (Free amino acids such as Vivonex, Tolerex)

Consider appetite stimulation
1.
2.

Megasteral accetate Megace (800 mg/d)
Note high cost and relatively small associated increase in lean body mass.
Dronabinol Marino[ (5 mg/day)
Note high cost and relatively small associated increase in lean body mass.

Common Medications Used in the Treatment of HIV
That May Affect Appetite and Nutrition
GI Side Affects

Interventions

AZT

nausea, diarrhea
(Common with high dosages
early in treatment)

Take with food
Symptoms often improve
with time
Consider decreasing dosage
if persistent symptoms

DDI

occasional nausea, diarrhea
pancreatitis (rare)

For minor GI symptoms,
can consider switching
between tablet and powder
formulations.

DDC

Nausea (occasional)
Mouth ulcers (rare)

Take with food.

D4T

Nausea (uncommon)

Take with food.

Bactrim

Nausea, diarrhea
Stomatitis (rare)
Glossitis (rare)

Consider change from qd to
3x/week dose for
pneumocystis prophylaxis

Dapsone

Nausea (rare)

Consider change
Options Include:
50 mg/d
100 mg/qod
200 mg/ q week

Rifabutin

Nausea, anorexia (rare)

Take with food.
Consider split dose (ie.
150mg bid) for
mycobacterium avium
prophylaxis.

Medication

The AIDS Consultation Service's AIDS Infonnation Hotline Phannacist
is available Monday - Friday 9:00 am - 4:00 pm
to answer any questions you may have regarding medications
used to treat HIV/AIDS and their side affects.

1-800-871-2701

Treatment of Depression In HIV
In the evaluation of the patient with poor nutrition, depression should be considered. Depressive symptoms
are not uncommon among HIV I AIDS patients. Depression may be initially manifested by weight loss and fatigue,
which are common complaints of HIV disease. The challenge is to tease out symptoms that are an appropriate
reaction to the disease from those that are due to HIV itself, and to determine whether or not a major depressive
disorder is present. Some of the symptoms to consider are decreased mood, general anhedonia, significant weight
loss or gain, insomnia or hypersomnia, motor agitation or retardation, fatigue, feelings of worthlessness, lack of
concentration, recurrent thoughts of death, and over reaction to health issues. While considering these, it is
beneficial to keep in mind that this patient may have had a predisposition to depression before the HIV I AIDS
diagnosis, and to obtain careful history of previous mood disturbances, etc.
The following charts from AIDS Clinical Care provide a suggested approach to the treatment of depression
in patients with HIV .

m.

I.

Failed Drug Trial for Depression

,!.

principles: choose by side effects, case profile,
what has failed, long-term plan

Depression Treatment
criteria for major depression

,!.
next drugs

yes

no
failed other treatments
other convincing evidence

,!.
,!.
,!.
,!.
,!.

.,,

"

yes

no

,!.

pharmacologic treatment
with psychotherapy

nonpharmacologic
treatment
(psychotherapy)

bupropion
trazodone
alternate tricyclic
serotonin specific reuptake inhib.
monoamine oxidase inhibitor
mood stabelizer augmentation
neuroleptic augmentation

benzodiazepine augmentation
Ritalin augmentation
Cytomel augmentation
sleep deprivat. augmentation
phototherapy
electroconvulsive therapy

On-Going Clinical Trials at AIDS Consultation

Service
II. Pharmacotherapy for Depression
primary symptoms
poor sleep
weight loss
anxiety
GI disturbance

Delavirdine In Combination with
AZT or DD/
hypersomnia
weight gain
suicide potential
chronicity

,!.

,!.

nortriptyline
desipramine

fluxetine
sertraline
paroxetine
venlafaxine

failure from side effects
(switch call of antidepressants)

~--------------------------------+
failure after good trial

,!.
lithium augmentation (risk/benefit)

,!.
next drug

Charts reprinted by permission of AIDS Clinical Care 1440 Main Street,
Waltham, MA 02154, Vol.6, Number 8, Glemi J. Treisman, M.D., Mental
Health Care of HIV Patients Part I: Managing Psychiatric Disease, pp 63-66,
1994.

Maine Medical Center's AIDS Consultation Service is
enrolling in these two clinical trials or a new anti-retroviral
drug, delavirdine, which is used in combination with AZT or
DDI. Patient enroUment is expected to continue for 6 months.
All antiviral medications, study related laboratory costs, and
research clinical visits are provided at no cost to the patient.
Physicians interested in referring patients for inclusion in this
2 year study should call the AIDS Consultation Service at
1-800-871-2701.

Open Label, Triple Antiviral
Combination Drug Study
(AZT, DD/ or DDC, plus delavirdine)
Patients with progression of ~ e in the 2 studies
noted above may, after 6 months on double combination
therapy, enroll in this open label triple combination therapy
trial. Antiretroviral medications, laboratory, and research
visits will be free to the patient as in the other 2 delavirdine
studies. The open label trial will continue ror 2 years.

World AIDS Cases
2,500,000*
US AIDS Cases
361,509
US AIDS Deaths
220,871
Total US cases and deaths reponed through 12131/93
530
Maine AIDS Cases
279
Maine AIDS Deaths
Total Maine cases and deaths reponed through 06/30/94
*Estimated
Upcoming HIV/AIDS Education
September 6, 1994
8:00 - 9:00 am
September 23, 1994
9:00 - 10:00 am
September 23, 1994
2:30 - 3:30 pm
September 26 & 27, 1994
September 27, 1994
October 6, 7, 8, 1994
October 16, 1994
November 2, 1994
November 28, 1994
8:00 - 10:00 am

Outpatient Management of Grand Rounds ... Family Practice Grand Rounds at Maine Medical Center
Presented by - Robert P. Smith, M.D. (207)871-2099
Pain Management in the Cancer and AIDS Patients ... NE Osteopathic Association (207)474-2357
Presented by - Owen Pickus, D.0.
HIV/AIDS Update for Physicians ...••• NE Osteopathic Association (207)474-2357
Presented by - David Loughran, 0.0.
HIV 101 & Care of PW A's at Home ... Hospice of Maine
Presented by - Sandra T. Putnam, RN, MSN, FNP (207)871-2099
Update from the International Conference on AIDS: Yokohama, Japan .. .Sponsored by New Eng. AIDS
Ed. and Training Center
HIV/AIDS in the Dental Setting ... Sponsored by New Eng. AIDS Ed. & Training Ctr - Maine
at the Comfort Inn, Augusta, Me.
Women's Health Care Issues Across the Life Span ... Sponsored by University of Southern Maine at the
Ramada Inn, Portland, Maine
Community Advocacy & Family Connections Contemporary Practice with HlVIAIDS ... Sponsored by
USM and ACS at Holiday Inn by the Bay, Portland, Me.
Psychosocial Issues & HIV ... University of New England, Biddeford, Maine
Presented by - Jane K. O'Rourke, LCSW (207)871-2099

If you are providing an HIV/AIDS related educational session, please let us know at (207)871-2099

Maine Medical Center
AIDS Consultation Service
22 Bramhall Street
Portland, Maine 04102
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